Huang M, Allen DR, Keller DM, Fadel PJ, Frohman EM, Davis SL. Impaired carotid baroreflex control of arterial blood pressure in multiple sclerosis. J Neurophysiol 116: 81-87, 2016. First published April 13, 2016 doi:10.1152/jn.00003.2016.-Multiple sclerosis (MS), a progressive neurological disease, can lead to impairments in the autonomic control of cardiovascular function. We tested the hypothesis that individuals with relapsing-remitting MS (n ϭ 10; 7 females, 3 males; 13 Ϯ 4 yr from diagnosis) exhibit impaired carotid baroreflex control of blood pressure and heart rate compared with sex, age, and body weight-matched healthy individuals (CON: n ϭ 10; 7 females, 3 males). At rest, 5-s trials of neck pressure (NP; ϩ40 Torr) and neck suction (NS; Ϫ60 Torr) were applied to simulate carotid hypotension and hypertension, respectively, while mean arterial pressure (MAP; finger photoplethysmography), heart rate (HR), cardiac output (CO; Modelflow), and total vascular conductance (TVC) were continuously measured. In response to NP, there was a blunted increase in peak MAP responses (MS: 5 Ϯ 2 mmHg) in individuals with MS compared with healthy controls (CON: 9 Ϯ 3 mmHg; P ϭ 0.005), whereas peak HR responses were not different between groups. At the peak MAP response to NP, individuals with MS demonstrated an attenuated decrease in TVC (MS, Ϫ10 Ϯ 4% baseline vs. CON, Ϫ15 Ϯ 4% baseline, P ϭ 0.012), whereas changes in CO were similar between groups. Following NS, all cardiovascular responses (i.e., nadir MAP and HR and percent changes in CO and TVC) were not different between MS and CON groups. These data suggest that individuals with MS have impaired carotid baroreflex control of blood pressure via a blunted vascular conductance response resulting in a diminished ability to increase MAP in response to a hypotensive challenge.baroreceptors; heart rate; sympathetic nervous system; carotid hypotension; carotid hypertension MULTIPLE SCLEROSIS (MS), the most common disabling neurological disorder of young adults, is a progressive autoimmune disease affecting the central nervous system (Edmonds et al. 2010). This disease results in the demyelination of axons leading to slowed or blocked nerve conduction and ultimately axonal loss within the brain and spinal cord. Abnormal nerve conduction resulting from demyelination disrupts communication to, from, and within the central nervous system causing a constellation of neurological clinical signs and symptoms (Lubin 2005;Oger 2007).Because the underlying pathophysiology of MS becomes more severe as areas of disease progression get larger and involve more of the central nervous system, it is likely the autonomic nervous system is affected (Lubin 2005). Case in point, impaired autonomic control of cardiovascular function has been reported in up to two-thirds of individuals with MS (Acevedo et al. 2000;Nasseri et al. 1998). The most perilous health-related concern related to this autonomic cardiovascular dysfunction is the prevalence of orthostasis-related symptomology (i.e., orthostat...